, Tracking Stock Market Picks
Enter Symbol:
Rating: DD
Buy $72
up 16.00 %

E.i. Du Pont De Nemours And Company (NYSE: DD) reiterated to Buy with price target $72 by Argus

Monday,  Nov 2, 2015  2:25 PM ET by Kristen Bailey

Here is more proof that the Argus rating can guide you in smart investing. Argus reiterated E.i. Du Pont De Nemours And Company (NYSE: DD) to Buy with price target
$72 with today's price of $64.06. Argus rated E.i. Du Pont De Nemours And Company (NYSE: DD) to Buy with price target $63 on 08/03/2015, when the price was $55.04. E.i. Du Pont De Nemours And Company's stock price gained 16% since then.
By following the previous Argus's recommendation on DD, you would have gained 16% in 91 days.

E.I. DuPont de Nemours is involved in science and technology in a range of disciplines including high-performance materials, specialty chemicals, pharmaceuticals and biotechnology. The company operates globally through strategic business units. Within the strategic business units, businesses manufacture and sell a wide range of products to many different markets, including the transportation, textile, construction, automotive, agricultural and hybrid seeds, nutrition and health, pharmaceuticals, packaging and electronics markets.

Argus Research is an independent research firm, and our business is producing, distributing and marketing high-quality investment and economic research. Our recommendations - BUY, HOLD and SELL - reflect the judgment of an analyst about a company's prospects as an investment in terms of value, expected growth and risks. Argus Research does not bring companies public, advise companies on mergers and acquisitions, broker trades, make markets in stocks or manage money. Our independence allows us to make critical judgments about companies that we might not be so free to make were we competing for a firm's underwriting business. Because we're not a broker/dealer, we don't have "inventory" of a stock that we have to move with a tainted recommendation. We have developed a six-point system for analyzing the stocks in our Universe of Coverage. We believe that this system

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy